Francesc Graus

Active 1983–2025

216
Papers
55,084
Citations
122
h-index
211
i10-index

Citations

Citations per year for Francesc Graus1985: 1 citations1986: 13 citations1987: 11 citations1988: 15 citations1989: 14 citations1990: 26 citations1991: 20 citations1992: 21 citations1993: 18 citations1994: 25 citations1995: 67 citations1996: 36 citations1997: 57 citations1998: 41 citations1999: 79 citations2000: 81 citations2001: 92 citations2002: 74 citations2003: 111 citations2004: 140 citations2005: 100 citations2006: 136 citations2007: 110 citations2008: 147 citations2009: 142 citations2010: 195 citations2011: 246 citations2012: 293 citations2013: 291 citations2014: 312 citations2015: 385 citations2016: 409 citations2017: 553 citations2018: 426 citations2019: 1,616 citations2020: 1,813 citations2021: 1,748 citations2022: 1,454 citations2023: 918 citations2024: 1,730 citations2025: 615 citations2026: 1 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,097 citing papers, 22.9% of this breakdownGermany: 804 citing papers, 8.8% of this breakdownChina: 750 citing papers, 8.2% of this breakdownUnited Kingdom: 664 citing papers, 7.2% of this breakdownFrance: 559 citing papers, 6.1% of this breakdownItaly: 540 citing papers, 5.9% of this breakdownSpain: 516 citing papers, 5.6% of this breakdownNetherlands: 285 citing papers, 3.1% of this breakdownCanada: 275 citing papers, 3% of this breakdownJapan: 261 citing papers, 2.8% of this breakdownAustralia: 247 citing papers, 2.7% of this breakdownSwitzerland: 237 citing papers, 2.6% of this breakdown
0%22.9%Other 21.1%

Fields

  • Medicine83.1%
  • Biochemistry, Genetics and Molecular Biology7.4%
  • Neuroscience5.3%
  • Immunology and Microbiology2.2%
  • Psychology0.8%
  • Engineering0.2%
  • Other1%

Topics

  • Autoimmune Neurological Disorders and Treatments14.2%
  • Peripheral Neuropathies and Disorders7.5%
  • Multiple Sclerosis Research Studies5.4%
  • Glioma Diagnosis and Treatment3.8%
  • CNS Lymphoma Diagnosis and Treatment2.9%
  • Lymphoma Diagnosis and Treatment2.2%
  • Other64%

Coauthors

All papers

Open in search
  1. A clinical approach to diagnosis of autoimmune encephalitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Neurology 2016 cited by 4,396

  2. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study

    Authors: , , , , , , , , , , , , , , , , , , - The Lancet Neurology 2013 cited by 3,094

  3. Antibody-Mediated Encephalitis

    Authors: , - New England Journal of Medicine 2018 cited by 1,315

  4. Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes

    Authors: , , , , , , , , , , , , , , , , , , - Neurology Neuroimmunology & Neuroinflammation 2021 cited by 708

  5. An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models

    Authors: , , , , , , , , , , - The Lancet Neurology 2019 cited by 858

  6. Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Izascun Arratibel, Gemma Aznar‐Laín, Paula Bellas-Lamas, Teresa de Jesús Bermejo, Sabas Boyero-Durán, Ana Camacho, Andrea del Campo, Dulce Campos, Verónica Cantarín Extremera, Cristóbal Carnero Pardo, David Conejo-Moreno, Marta Dapena, David Dacruz-Álvarez, Verónica Delgadillo-Chilavert, Àngela Deyà‐Martínez, Jordi Estela-Herrero, A. de Felipe, Elisa Fernández-Cooke, Joaquín Alejandro Fernández‐Ramos, Clàudia Fortuny, Juan Carlos García‐Moncó, Teresa Gili, Verónica González-Álvarez, Robert Güerri, Sara Guillén, Antonio Hedrera-Fernández, María López, Eduardo López‐Laso, María Lorenzo-Ruiz, Marcos Madruga, Ignacio Málaga, Itxaso Martí, Xavier Martínez-Lacasa, Lucía Martín-Viota, Leticia Martín Gil, María-Jesús Martínez-González, Antía Moreira, María Concepción Miranda-Herrero, L. Monge Galindo, Beatriz Muñoz Cabello, Juan Navarro‐Morón, Olaf Neth, Antoni Noguera‐Julián, Noemí Núñez‐Enamorado, Virginia Pomar, Juan C Portillo-Cuenca, M.S. Perez Poyato, Luís Prieto, Luís Querol, Eloy Rodríguez‐Rodríguez, Silvana Sarria‐Estrada, Concepción Sierra, Pere Soler‐Palacín, Víctor Soto-Insuga, Laura Toledo-Bravo, Miguel Tomás, Carmen Torres-Torres, Eulàlia Turón, Ana Zabalza - The Lancet Neurology 2018 cited by 648

  7. Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System

    Authors: , , - Physiological Reviews 2017 cited by 635

  8. LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2019 cited by 261

  9. Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis

    Authors: , , , , , , , , , , , , - Brain 2012 cited by 687

  10. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study

    Authors: , , , , , , , , , , , - The Lancet Neurology 2013 cited by 1,286

  11. Report of an International Workshop to Standardize Baseline Evaluation and Response Criteria for Primary CNS Lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2005 cited by 906

  12. Clinical manifestations of the anti-IgLON5 disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Neurology 2017 cited by 414

  13. A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study

    Authors: , , , , , , , , , , , , , , - The Lancet Neurology 2014 cited by 551

  14. Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gema Arriola-Pereda, Gemma Aznar‐Laín, Maite Benavides-Medina, Teresa de Jesús Bermejo, Raquel Blanco-Lago, Eva Caballero, Rocío Calvo, Ana Camacho Salas, David Conejo-Moreno, Verónica Delgadillo-Chilavert, Amagoia Elosegi-Castellanos, Vanesa Esteban Canto, Joaquín Alejandro Fernández‐Ramos, Montserrat García-Puig, Ainhoa García-Ribes, Hilario Gómez-Martín, Desire Gonzalez-Barrios, Luis González‐Gutiérrez‐Solana, Sara Jimena-Garcia, María Jiménez‐Legido, Natalia Juliá‐Palacios, Eduardo López‐Laso, Itxaso Martí, Marta Martínez González, Lucía Martín-Viota, Simone Mattozi, Elena Maqueda-Castellote, Maria del Mar Mendibe, Maria D Mora-Ramírez, Beatriz Muñoz Cabello, Juan Navarro‐Morón, Tania Nunes-Cabrera, Gabriela Orellana, Berta Pujol-Soler, Luís Querol, Alfredo Ramírez, María Isabel Rodríguez-Lucenilla, Cesar Ruiz, Víctor Soto-Insuga, Laura Toledo Bravo de Laguna, Eulalia Turón‐Viñas, María Vázquez López, Cristina Villar‐Vera - The Lancet Neurology 2020 cited by 326

  15. Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Agustín F. Fernández, Mario F. Fraga, Ibán Aldecoa, Leire Pedrosa, Francesc Graus, Noemí Vidal, Fina Martínez‐Soler, Avelina Tortosa, Cristina Carrato, Carmen Balañá, Matthew W. Boudreau, Paul J. Hergenrother, Peter Kötter, Karl-Dieter Entian, Jürgen Hench, Stephan Frank, Sheila Mansouri, Gelareh Zadeh, Pablo D. Dans, Modesto Orozco, George Thomas, Sandra Blanco, Joan Seoane, Thomas Preiß, Pier Paolo Pandolfi, Manel Esteller - Acta Neuropathologica 2019 cited by 194

  16. Diagnostic criteria for autoimmune encephalitis: utility and pitfalls for antibody-negative disease

    Authors: , - The Lancet Neurology 2023 cited by 166

  17. Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice

    Authors: , , , , , , , , , , , , , - Brain 2014 cited by 493

  18. The clinical spectrum of Caspr2 antibody–associated disease

    Authors: , , , , , , , , , , , , - Neurology 2016 cited by 433

  19. A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis

    Authors: , , , , , - Neurology 2018 cited by 295

  20. Molecular Diagnosis of Diffuse Gliomas through Sequencing of Cell-Free Circulating Tumor DNA from Cerebrospinal Fluid

    Authors: , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2018 cited by 190

  21. Neuropathological criteria of anti-IgLON5-related tauopathy

    Authors: , , , , , , , , , , , , , , , , - Acta Neuropathologica 2016 cited by 239

  22. Paraneoplastic neurological syndromes in the era of immune-checkpoint inhibitors

    Authors: , - Nature Reviews Clinical Oncology 2019 cited by 269

  23. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series

    Authors: , , , , , , , - The Lancet Neurology 2010 cited by 1,357

  24. Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies

    Authors: , , , , , , , , , , , , , , , , , , - The Lancet Neurology 2014 cited by 615